Note: Ingredients listed on restricted chemical lists
EC/CAS
247-852-1/26628-22-8
Name of the chemical
Sodium Azide
Concentration
1x2.5 1x1.0
General Information
Revision date
2015-04-28
Product name
Biokit/Inova Diagnostics, Inc
Product Synonyms
S A F E T Y D A T A S H E E T
CAS No.
26628-22-8
1.2.1 Relevant identified uses
The Sure-Vue CRP reagent is a suspension of polystyrene latex particles of uniform size coated with the IgG fraction of an anti-human CRP specific serum. Latex particles allow visual observation of the antigen-antibody reaction. If the reaction takes place, due to the presence of C-reactive protein in the serum, the latex suspension changes its uniform appearance and a clear agglutination becomes evident
Icons in SDS
Company Information
company name
Biokit/Inova Diagnostics, Inc
GHS Information
Signal word
None
Section 2
SECTION 2: Hazards identification
GHS Classification Emergency Overview
2.3 Other hazards
No known OSHA hazards
Other hazards which do not result in classification
Not a dangerous substance or mixture according to the Globally Harmonized System (GHS).
2.1 Classification of the substance or mixture
N/A
Hazard pictograms
None
Signal word
None
Hazard statements
None
Precautionary statements
None
Potential health effects
Inhalation: May be harmful if inhaled. May cause respiratory tract irritation. Skin: May be harmful if absorbed through the skin. May cause skin irritation. Eyes: May cause eye irritation. Ingestion: May be harmful if swallowed. Target Organs: None identified. Human Source Material: Treat as potentially infectious. Serum used in the preparation of this product has been tested by FDA approved methods and found non- reactive for the presence of Hepatitis B surface antigen (HBsAg), antibody to human immunodeficiency virus (HIV) and Hepatitis C virus (HCV). No known test method can offer complete assurance that Hepatitis B virus, HIV, HCV, or other infectious agents are absent. Handle these controls and all patient samples at Biosafety Level 2 as recommended in the Biosafety in Microbiological and Biomedical Laboratories, Centers for Disease Control and Prevention/National Institutes of Health, Fifth Edition, 2007. NOTE: Physical and health hazard information for this component has not been determined. Any physical and health information noted is based on evaluation of data for pure ingredients and concentration of ingredients as packaged. NFPA: HEALTH = 0, FIRE = 0, REACTIVITY = 0 HMIS: HEALTH = 0, FLAMMABILITY = 0, PHYSICAL HAZARDS = 0
